Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;24(16):859-870.
doi: 10.2217/pgs-2023-0164. Epub 2023 Nov 9.

Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives

Meghna Bhatt  1 , Beth N Peshkin  2 , Sadaf Kazi  1   3 , Marc D Schwartz  2 , Nadia Ashai  1   4 , Sandra M Swain  1   5 , D Max Smith  1   2
Affiliations

Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives

Meghna Bhatt et al. Pharmacogenomics. 2023 Nov.

Abstract

Aim: Identify oncology healthcare providers' attitudes toward barriers to and use cases for pharmacogenomic (PGx) testing and implications for prescribing anticancer and supportive care medications. Materials & methods: A questionnaire was designed and disseminated to 71 practicing oncology providers across the MedStar Health System. Results: 25 of 70 (36%) eligible oncology providers were included. 88% were aware of PGx testing and 72% believed PGx can improve care. Of providers who had ordered a medication with PGx implications in the past month, interest in PGx for anticancer (90-100%) and supportive care medications (>75%) was high. Providers with previous PGx education were more likely to have ordered a test (odds ratio: 7.9; 95% CI: 1.1-56; p = 0.0394). Conclusion: Oncology provider prescribing practices and interest in PGx suggest opportunities for implementation.

Keywords: oncology; pharmacogenetics; pharmacogenomics; pharmacy; survey.

PubMed Disclaimer

LinkOut - more resources